Methyl3-bromo-1h-pyrazolo[4,3-b]pyridine-6-carboxylate, 98%, 10g

(4-phenyl-1,3-thiazol-2-yl)methanol, 95.0%, 100mg

(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 25g

3,3-dimethyl-2-pyrrolidinone, 95.0%, 25g

2,7-Dimethyl-1,8-naphthyridine, 97%, 100mg

FRAX597, 98%, 250mg

2-Methyl-2-[3-(trifluoromethyl)phenyl]propanoic acid, 95.0%, 1g

(S)-Methyl 2-hydroxy-3-methylbutanoate, 95.0%, 1g

5-Methoxy-2-methylpyridine, 95.0%, 250mg

N-Hydroxysuccinimide [Coupling Reagent for Peptide]>98.0%(GC)(T)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-fluorophenyl)-2-methylpropanoic acid, 97%, 1g

(2R,3S,5R)-5-(2-amino-6-methoxy-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 98%, 100mg

2-(2,3-Dihydro-1H-inden-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g